clinical trial · NCT07654751
A Remotely Conducted Study to Assess Concentration of TREMFYA in Breast Milk of Lactating Women Who Are Receiving TREMFYA Therapeutically
Janssen Research & Development, LLC·phase4·recruiting·n = 10
PsoriasisColitis, UlcerativeCrohn DiseaseArthritis, PsoriaticBreast Milk Sample CollectionGuselkumab
brief summary
The purpose of this post-marketing study is to assess the amount of guselkumab in breast milk of lactating women receiving guselkumab as part of their standard clinical care provided by their treating physician, for any of the approved indications. This is a fully remote (virtual) study. Participants can complete all study-related activities, including consent, study visits, and breast milk sample collection, from home without attending an in-person study site.
started
Aug 7, 2026
primary completion
Aug 31, 2027
completion
Aug 31, 2027
last updated
Nov 3, 2026
official title
A Phase 4, Open-Label, Milk-Only Lactation Study to Assess Concentration of TREMFYA in Breast Milk of Lactating Women Who Are Receiving TREMFYA Therapeutically
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol